BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 17484137)

  • 61. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
    Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
    J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
    Hezareh M
    Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J; Kräusslich HG
    FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.
    Yin H; Zhang Y; Zhou X; Zhu H
    Mol Biol Rep; 2011 Nov; 38(8):5071-8. PubMed ID: 21181272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor.
    Pan C; Mezei M; Mujtaba S; Muller M; Zeng L; Li J; Wang Z; Zhou MM
    J Med Chem; 2007 May; 50(10):2285-8. PubMed ID: 17444627
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of linker histone H1 on chromatin remodeling.
    Hill DA
    Biochem Cell Biol; 2001; 79(3):317-24. PubMed ID: 11467745
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histone acetylation beyond promoters: long-range acetylation patterns in the chromatin world.
    Forsberg EC; Bresnick EH
    Bioessays; 2001 Sep; 23(9):820-30. PubMed ID: 11536294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
    Yang XJ; Seto E
    Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcription of HIV: Tat and cellular chromatin.
    Gatignol A
    Adv Pharmacol; 2007; 55():137-59. PubMed ID: 17586314
    [No Abstract]   [Full Text] [Related]  

  • 71. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SIRT1 regulates HIV transcription via Tat deacetylation.
    Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
    PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histone acetylation and chromatin remodeling.
    Gregory PD; Wagner K; Hörz W
    Exp Cell Res; 2001 May; 265(2):195-202. PubMed ID: 11302684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of histone deacetylation enhances endotoxin-stimulated transcription but does not reverse endotoxin tolerance.
    Yoza BK; Hu JY; McCall CE
    J Endotoxin Res; 2002; 8(2):109-14. PubMed ID: 12028750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanisms of HDAC inhibitor-induced thrombocytopenia.
    Matsuoka H; Unami A; Fujimura T; Noto T; Takata Y; Yoshizawa K; Mori H; Aramori I; Mutoh S
    Eur J Pharmacol; 2007 Oct; 571(2-3):88-96. PubMed ID: 17628529
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Histone deacetylases: complex transducers of nuclear signals.
    Johnson CA; Turner BM
    Semin Cell Dev Biol; 1999 Apr; 10(2):179-88. PubMed ID: 10441071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting aberrant transcriptional repression in acute myeloid leukemia.
    Moe-Behrens GH; Pandolfi PP
    Rev Clin Exp Hematol; 2003 Jun; 7(2):139-59. PubMed ID: 14763160
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression.
    Magnani M; Balestra E; Fraternale A; Aquaro S; Paiardini M; Cervasi B; Casabianca A; Garaci E; Perno CF
    J Leukoc Biol; 2003 Nov; 74(5):764-71. PubMed ID: 12960277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy.
    Victoriano AF; Okamoto T
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):125-38. PubMed ID: 22077140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcription regulation by histone deacetylases.
    Wang S; Yan-Neale Y; Zeremski M; Cohen D
    Novartis Found Symp; 2004; 259():238-45; discussion 245-8, 285-8. PubMed ID: 15171258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.